Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3
2018 · Science Translational Medicine · 135 citations
https://doi.org/10.1126/scitranslmed.aat5775
T
T. Noelle Lombana
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
597
Citations
10
h-index
10
i10-index
T. Noelle Lombana is an academic researcher from Rapt Therapeutics (United States). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Tuberculosis Research and Epidemiology & CAR-T cell therapy research. The author has an h-index of 10, co-authored 25 publications.
ORCID: 0000-0002-7017-2807Papers by this author
worksOptimizing antibody expression by using the naturally occurring framework diversity in a live bacterial antibody display system
2015 · Scientific Reports · 30 citations
https://doi.org/10.1038/srep17488
Lipid nanoparticle-encapsulated <i>Dnai1</i> mRNA rescues ciliary activity in primary ciliary dyskinesia mouse cell models
2025 · Journal of Cell Science · 3 citations
https://doi.org/10.1242/jcs.264068
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat